Reporting to the CEO, focused on expanding own commercial operations in LATAM, based on establishing Biosidus’ affiliate in Colombian and starting own Market companies in Mexico, Brazil and Ecuador whereas completing a turnaround restructuring process in the region.

Reporting to the CEO, currently leading country’s operation in LATAM (Distributors, Affiliates & Commercial Offices). Full P&L and operational responsibility for the business in Latin America (BRA, MEX, ARG, COL, ECU, UY, CHL and Small Countries). Led successful transformational efforts and established, developed and implemented new business strategy for territories in LATAM (opened the first two affiliate outside Argentina: Colombia & México). Currently leading 65% of total corporate sales. HC: 58 reports in the region.Responsible for Global BD, leading the corporate strategy for new in-license opportunities as well as Company’s pipeline strategy, including new products in R&D.

Reporting to the CEO, leading own country’s operation in Argentina. Responsible for a US$25 Mio business in Argentina, leading the promotion, marketing, sales, Access and customer service areas of the organization, with 26 colleagues.

Managed Biogen’s Partnering & Alliance in LATAM region. GM role with 4 direct reports including: Countries’ BU Managers, Regional Marketing Manager; and 42 indirect reports also including local Sales, Marketing & Access TEAMS. Implemented S&OP process for the franchise. Delivered results through improvements of SFE processes. Cross functional model integrating Finances, HR, Supply & Manufacturing, PV, QA. Developed and implemented regional commercial strategies for the therapeutic areas. Full Regional P&L responsibility. Ensured and lead a successful Regulatory and Market Access strategy in the territories. Implemented successful launches in the region.

Partnering with Gilead, bringing new therapies in Hepatitis C (Sovaldi & Harvoni). Created the Start-up organization for Gilead in Mexico. Developed the Strategic Launch Plan for Sovaldi as well as the Operational design, Legal & Regulatory needs for the new legal entity in Mexico. Define optimal commercial & access structure. Created and Lead a comprehensive team including Sales, Marketing, Access, Medical and MSLs as well as the supportive regulatory functions (Regulatory, Supply, QA, PhV).

Promoted from HQ in Barcelona to lead the largest commercial organization in the company. Managed and lead both Marketing and Sales Organization: Sales Force Structure: 153 Representatives, 15 District Managers, 2 Regional Managers and 1 National Sales Manager. Marketing Structure: 6 Product Managers, 1 Medical Manager, Marketing Manager. Business Support & Service: 1 Business Analyst, 3 Sales Force productivity Managers. Implemented new CRM for Sales Force Management, New Incentive & Compensation Tool and New Commercial Model with Distributors. Implemented new Sales Training and coaching plans. Launched two Key brands in Respiratory and Gastroenterology areas.

Managed and lead a large cross-functional team including: Finance, Regulatory, Alliance Management, Legal, Project Management, Q&A / Safety, R&D, Marketing and Sales. Introduced process’ improvements to maximize the support in all functions and areas. Oversaw the operation and budget control to secure local sales of around €130mio. Partners management. Developed strategic projects to implement the global launch of a company’s blockbusters in Respiratory. Developed strategic initiatives for potential start-ups in Asia-Pac. Transformed the Representative Chief Office in China towards a fully license out model. Executed a number of successful deals in Australia, China, Japan and South East Asia.Ad-hoc project: Entry model and start-up operations in Brazil

Business Planning and Key project support for market companies in Europe. Deputy General Manager in Poland (Aug 08/March09), leading the startup of the new affiliate. Implemented a Sales Force Excellence project in key EU markets. Managed Middle- East partners. Implementing a strategic plan that duplicated the turnover in two years’ period in Middle-East. Redesigned company’s strategy in the Middle-East region through a broad optimization plan including key regulatory and supply activities. Managed and lead a large cross-functional group including: Finance, Regulatory, Alliance Management, Legal, Project Management, Q&A / Safety, R&D, Marketing.

Managed global sales at the end of 2005 of €93M starting in €86M for the Migraine Franchise. Implemented the re-positioning and segmentation strategy to optimize Migraine Franchise performance in the territories, in particular for the US market. Recognized within the company in providing strategic solutions to revitalize this key strategic brand for Almirall. Planed, organized and managed the product’s life cycle strategy including switching into the OTC market. Lead the Launch Strategy for Sativex, the THC:CBD Cannabinoid Modulator (A first-in-class Cannabis Based Medicine) for the treatment of severe pain and MS. Worked along the Global Brand Team, a matrix organization of fifteen (15) members. Successfully managed the brand strategy including: launch sequence based on regulatory strategy, positioning and segmentation, pricing and reimbursement, supply chain and tactical programs. Lead the early positioning strategy along with R&D teams.Ad-hoc project 1: “Best in Class” Marketing Excellence Program: To set analytical tools designed to guide the Market Companies through a Marketing Planning Process. Developed a methodology, building robust marketing process and a common marketing language and practices across the International Almirall’s organization.Ad-hoc project 2: “Ready To Launch” Marketing Excellence Program: Aa comprehensive strategic tool and launch road-map, to establish and execute all activities that occur from Phase I to product’s launch. It includes a full process map, best practice guidelines, strategy development process and templates for activities to assist the launch process.

First Roche’s employee (commercial) moving to HQ in Basel from LATAM, to support the launch of a new product for Osteoporosis (Strategic alliance with GSK). Implemented the global Patient relationship program as Global task force leader. Achieved successful implementation of a series of Roadshow for the internal launch of this project. Achieved implementation of the Strategic Launch Concept. Executed the development of branding and positioning strategy. Lead the KOL development activities as a Global task force leader. Lead the Packaging and compliance tools as a Global task force leader in this area. Implemented the co-promotion agreements for Asia and Latin-America regions. Lead the implementation of Global Congresses and PR activities. Alliance experience as member of the Join Commercial Sub-team and the Business Alliance Operational Team. Extensive experience in a complex matrix organization

Responsible for managing Tranquilizer, Obesity and Dermatology products. Development of new strategies and implementation of tactical plans through sales forces. Recognized as an effective communicator and leader to a sales force of 130 reps. Hired and challenged to turn around history of declining sales of the Roche’s tranquilizers, breaking sales trend from 10,1% share to 13,5% share. Successful development of re-positioning of tranquilizer portfolio. Successful launch of Lexotanil CR. Turned the product from decline to growth in market share. Successful development and implementation of the first face-to-face Patient Support Program in Argentina for Xenical. Successful development and implementation of a Money back guarantee program for Roaccutan. Later rolled-out in the US, Canada, UK, Brazil and S. Africa. Extensive experience gained in training sales forces. Recognized as an effective leader to sales force

Responsible for operation in both countries. Introduced process improvements to maximize performance. Responsible for pricing & reimbursement strategy. Managed Regulatory and political affairs, Government, Institutions and Key customers relationship. Developed of a new sales force incentives systems. Managed and defined Sales Force allocation and execution. Portfolio and Product Strategy definition. Full P&L and business statement responsibility. Oversight of all finance, business development, marketing, human resources and administrative affairs. Follow-up of macro and micro-economic variables that could affect the normal development of the business.

Responsible for managing Osteoporosis and NAIDS areas. Responsible for managing 60% of the portfolio reaching sales of around U$D 30mio. Implemented the first “Patient Support Program” in Argentina. Responsible for the tactical implementation through 109 rep’s

National Sales Manager Rheumatology (Two years)District Manager / Supervisor (One year)Sales Representative (Two years)